Atara receives action date for tabcel
Thousand Oaks-based Atara Biotherapeutics announced that its partner, Pierre Fabre Pharmaceuticals, received acceptance by the U.S. Food and Drug Administration of the Biologics License Application for tabelecleucel, Atara’s lead product, on Oct. 14. With the notice, the FDA also set a target action date for the drug on March 31. Tabelecleucel, sold under the brand Read More →

Atara resubmits Ebvallo BLA to FDA
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Longtime Teledyne executive announces retirement
Jason VanWees, Teledyne Technologies’ Vice Chairman, announced that he will be retiring from his position on Feb. 1, 2027, at age 55. VanWees joined Teledyne before the company’s spin-off in 1999 and was named vice chairman in 2021. He spoke at a Ventech event in Santa Barbara in 2023, detailing Teledyne’s legacy as well as Read More →

Ag roundup: Mission sales up; Limoneira focuses on non-ag activity
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

AeroVironment piles on wins with latest earnings
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.








